Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

SOHO 2023 | Ongoing clinical trials to look out for in lymphoma

Tycel Phillips • 7 Sep 2023

SOHO 2023

Diffuse Large B-Cell Lymphoma Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma Acalabrutinib Antibodies Bendamustine BTK inhibitors Ibrutinib Rituximab Venetoclax

ECHO SYMPATICO

Tycel Phillips, MD, City of Hope, Duarte, CA, provides an overview of ongoing trials in lymphoma, including the Phase III SYMPATICO trial (NCT03112174), the Phase III ECHO trial (NCT02972840), and several other trials exploring novel treatment combinations in diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL). This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

An update from ASH 2023: advancements in NHL treatment

Tycel Phillips • 10 Dec 2023

A retrospective analysis of real-world data from patients treated for R/R follicular lymphoma

Tycel Phillips • 10 Dec 2023

Optimal sequencing of CAR-T and bispecifics in NHL

Tycel Phillips • 10 Dec 2023

GLOBRYTE: investigating glofitamab monotherapy in patients with R/R MCL

Tycel Phillips • 10 Dec 2023

Related Videos

Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS

Sridhar Chaganti • 16 Apr 2024

The role of CAR-T therapy for lymphoma in 2024: expert session highlights

Sridhar Chaganti • 16 Apr 2024

Promising novel immunotherapeutic approaches in lymphoma

Gloria Iacoboni • 15 Apr 2024

AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study

Jacopo Mariotti • 15 Apr 2024